Hap Trading, LLC Cure Vac N.V. Call Options Transaction History

Hap Trading, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 12, 2023	BUY	$6.38 - $12.5 $97,614 - $191,250	15,300 New	15,300 $4,000
Q1 2022 May 12, 2022	SELL	$14.73 - $35.25 $491,982 - $1.18 Million	-33,400 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$33.72 - $48.22 $1 Million - $1.44 Million	-29,800 Reduced 47.15%	33,400 $10,000
Q1 2021 May 14, 2021	SELL	$79.79 - $126.29 $797,900 - $1.26 Million	-10,000 Reduced 13.66%	63,200 $88,000
Q4 2020 Feb 16, 2021	BUY	$46.76 - $136.27 $3.42 Million - $9.97 Million	73,200 New	73,200 $124,000

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $499M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.